McKay KA - Search Results

1

Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis: A Swedish Nationwide Study.

Mouresan EF, Mentesidou E, Berglund A, McKay KA, Hillert J, Iacobaeus E. Mouresan EF, et al. Among authors: mckay ka. Neurology. 2024 Mar 26;102(6):e208051. doi: 10.1212/WNL.0000000000208051. Epub 2024 Feb 23. Neurology. 2024. PMID: 38394472 Free PMC article.

2

Familial risk of early- and late-onset multiple sclerosis: a Swedish nationwide study.

Song J, Westerlind H, McKay KA, Almqvist C, Stridh P, Kockum I, Hillert J, Manouchehrinia A. Song J, et al. Among authors: mckay ka. J Neurol. 2019 Feb;266(2):481-486. doi: 10.1007/s00415-018-9163-6. Epub 2018 Dec 21. J Neurol. 2019. PMID: 30578428 Free PMC article.

3

Long-term disability progression of pediatric-onset multiple sclerosis.

McKay KA, Hillert J, Manouchehrinia A. McKay KA, et al. Neurology. 2019 Jun 11;92(24):e2764-e2773. doi: 10.1212/WNL.0000000000007647. Epub 2019 May 15. Neurology. 2019. PMID: 31092624 Free PMC article.

4

Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple Sclerosis.

McKay KA, Manouchehrinia A, Berrigan L, Fisk JD, Olsson T, Hillert J. McKay KA, et al. JAMA Neurol. 2019 Sep 1;76(9):1028-1034. doi: 10.1001/jamaneurol.2019.1546. JAMA Neurol. 2019. PMID: 31206130 Free PMC article.

5

Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.

Binzer S, McKay KA, Brenner P, Hillert J, Manouchehrinia A. Binzer S, et al. Among authors: mckay ka. Neurology. 2019 Dec 10;93(24):e2216-e2223. doi: 10.1212/WNL.0000000000008617. Epub 2019 Nov 8. Neurology. 2019. PMID: 31704791 Free PMC article.

6

Determinants of quality of life in pediatric- and adult-onset multiple sclerosis.

McKay KA, Ernstsson O, Manouchehrinia A, Olsson T, Hillert J. McKay KA, et al. Neurology. 2020 Mar 3;94(9):e932-e941. doi: 10.1212/WNL.0000000000008667. Epub 2019 Nov 15. Neurology. 2020. PMID: 31732567 Free PMC article.

7

Long-term Socioeconomic Outcomes Associated With Pediatric-Onset Multiple Sclerosis.

McKay KA, Friberg E, Razaz N, Alexanderson K, Hillert J. McKay KA, et al. JAMA Neurol. 2021 Apr 1;78(4):478-482. doi: 10.1001/jamaneurol.2020.5520. JAMA Neurol. 2021. PMID: 33616605 Free PMC article.

8

Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: A study of the Swedish multiple sclerosis registry.

Spelman T, Forsberg L, McKay K, Glaser A, Hillert J. Spelman T, et al. Mult Scler. 2022 Jun;28(7):1051-1059. doi: 10.1177/13524585211026272. Epub 2021 Jul 2. Mult Scler. 2022. PMID: 34212816

9

Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study.

McKay KA, Wickström R, Hillert J, Karrenbauer VD. McKay KA, et al. Sci Rep. 2021 Sep 17;11(1):18528. doi: 10.1038/s41598-021-97543-6. Sci Rep. 2021. PMID: 34535701 Free PMC article.

10

Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis Relapse.

McKay KA, Bedri SK, Manouchehrinia A, Stawiarz L, Olsson T, Hillert J, Fink K. McKay KA, et al. Ann Neurol. 2022 Mar;91(3):417-423. doi: 10.1002/ana.26301. Epub 2022 Jan 24. Ann Neurol. 2022. PMID: 34984719 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters